New study ties weight-loss drugs Wegovy, Ozempic to serious gastrointestinal conditions Issues like pancreatitis, stomach paralysis higher among patients using GLP-1 inhibitor medications Medicines in the same class as Novo Nordisk's popular weight-loss therapy Wegovy may carry an increased risk of pancreatitis, intestinal blockage and stomach paralysis compared to an older obesity drug, according to a study published on Thursday
Parents of a child with PCD, who are carriers of the defective gene, may excrete two to three times the normal amount of carnitine in their urine
Common Mistakes We See People Make with L-Carnitine Over the years, our team has seen a few recurring pitfalls that prevent people from getting the results they want
Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomska G
For instance, in the FLOW trial, only 277 participants in the combination group compared to 1,490 receiving semaglutide alone
CZ CELLGENE Discover: A single-cell data platform for scalable exploration, analysis and modeling of aggregated data